Ameriprise
LIV

Ameriprise’s SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) LIV Stock Holding History

Ameriprise’s Portfolio LIV Stock Details LIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-834
Closed – – 5312
2014
Q3 		$0 Hold
834
– – ﹤0.01% 6144
2014
Q2 		$0 Hold
834
– – ﹤0.01% 5934
2014
Q1 		$0 Hold
834
– – ﹤0.01% 5625
2013
Q4 		$0 Hold
834
– – ﹤0.01% 5886
2013
Q3 		$0 Hold
834
– – ﹤0.01% 5873
2013
Q2 		$0 Buy
+834
New – ﹤0.01% 5682

Ameriprise's LIV Position: Q4 2014 in Review

Ameriprise sold out of SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) (LIV) in Q4 2014, closing a stake of 834 shares.

Ameriprise first reported a position in LIV in Q2 2013 and held it in 6 quarters. The position peaked at $0 in Q3 2014. 1 fund tracked by Wall St. Rank holds LIV as of Q4 2014.

  • Ameriprise reported no remaining SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 834 SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) shares in Q4 2014.
  • Ameriprise first reported a position in SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) in Q2 2013 and held it in 6 quarters.
  • Ameriprise's SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) position peaked at $0 in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SAMARITIAN PHARMACEUTICALS, INC. COM (NEW) as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.